Recursion Pharmaceuticals, Inc. Class A RXRX
NASDAQ · United States · Health Technology
$4.13+0.10 (+2.48%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -0.25 | -0.24 | -4.2% | $7.30M | -33.4% | -3.9%$3.31→$3.18 |
| Q1 2026 | 2026-05-06 | -0.22 | -0.26 | +15.4% | — | — | -3.0%$3.37→$3.27 |
| Q4 2025 | 2026-02-25 | -0.21 | -0.32 | +34.4% | — | — | +6.8%$3.53→$3.77 |
| Q3 2025 | 2025-11-05 | -0.36 | -0.38 | +5.3% | — | — | -7.6%$5.00→$4.62 |
| Q2 2025 | 2025-08-05 | -0.41 | -0.35 | -17.1% | — | — | — |
| Q1 2025 | 2025-05-05 | -0.50 | -0.52 | +3.8% | — | — | — |
| Q4 2024 | 2025-02-28 | -0.53 | -0.42 | -26.2% | — | — | — |
| Q3 2024 | 2024-11-06 | -0.34 | -0.33 | -3.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.